PREFACE This document is the ninth in a series constituting a "public record" of activities in regard to the National Institutes of Health (NIH) Guidelines for recombinant DNA research. The first eight volumes cover events from February 1975 through September 1984. This ninth volume covers events from September 1984 through March 1985. Volumes 1 through 5 in this series may be purchased from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, D.C. 20402, or viewed in some 600 public libraries of the GPO depository system. The GPO stock number of Volume 1 is 017-004-00398-6; Volume 2, 017-040-00422-2 and (supplement: Environmental Impact Statement) 017-040-00413-3; Volume 3, 017-040-00429-0 and (appendices) 017-040-00430-3; Volume 4, 017-040-00443-5 and (appendices) 017-040-00442-7; and Volume 5, 017-040-00470-2. Volumes 6, 7, and 8 are available from the Office of Recombinant DNA Activities, National Institutes of Health, Building 31, Room 3B10, Bethesda, Maryland 20892. CONTENTS Federal Register of September 20, 1984, announcing proposed Minutes of the Subgroup of the RAC Working Group on Human Minutes of the RAC Working Group on Release into the Environment meeting, October 5, 1984 Minutes of the RAC Working Group on Human Gene Therapy meeting, October 12, 1984. . Minutes of the RAC Working Group on Release into the Minutes of the RAC Working Group on Human Gene Therapy Federal Register of January 22, 1985, requesting public comment . . . . . . Minutes of the RAC Working Group on Biotechnology Coordination Federal Register of March 11, 1985, describing recommendations made at the RAC meeting, October 29, 1985, and promulgating one 426 |